Indeed, our data showed that forced expression of DHCR24 increases cellular 27HC content without statistically affecting cholesterol content in melanoma cells and, moreover, is associated with melanoma spheroid expansion and vemurafenib resistance. This evidence concerns the gene DHCR24 and melanoma.